Selected research
Industry Research
Drug Containment Solution Industry Research Report 2026
Market perspective
The global Drug Containment Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Containment Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Containment Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Containment Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Containment Solution include Stevanato Group, BD, AptarGroup, Hergesheimer AG, Catalent, Inc., West Pharmaceutical Services, Inc., Schott AG, Stearate Group and NIPRO, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Containment Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Containment Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Containment Solution Market by Company
Stevanato Group
BD
AptarGroup
Hergesheimer AG
Catalent, Inc.
West Pharmaceutical Services, Inc.
Schott AG
Stearate Group
NIPRO
Owen Mumford Limited
Psalmed AG
Drug Containment Solution Segment by Type
Vials
Ampoules
Bottles
Drug Containment Solution Segment by Application
Hospitals
Clinics
Home Care Settings
Ambulatory Surgical Centers
Drug Containment Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Containment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Containment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Containment Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Containment Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vials
- Ampoules
- Bottles
Applications
- Hospitals
- Clinics
- Home Care Settings
- Ambulatory Surgical Centers
Companies covered
- Stevanato Group
- BD
- AptarGroup
- Hergesheimer AG
- Catalent, Inc.
- West Pharmaceutical Services, Inc.
- Schott AG
- Stearate Group
- NIPRO
- Owen Mumford Limited
- Psalmed AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Containment Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Vials
- 2.2.3 Ampoules
- 2.2.4 Bottles
- 2.3 Drug Containment Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Home Care Settings
- 2.3.5 Ambulatory Surgical Centers
- 2.4 Assumptions and Limitations
3 Drug Containment Solution Breakdown Data by Type
- 3.1 Global Drug Containment Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Containment Solution Forecasted Market Size by Type (2027-2032)
4 Drug Containment Solution Breakdown Data by Application
- 4.1 Global Drug Containment Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Containment Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Containment Solution Market Perspective (2021-2032)
- 5.2 Global Drug Containment Solution Growth Trends by Region
- 5.2.1 Global Drug Containment Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Containment Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Containment Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Containment Solution Market Dynamics
- 5.3.1 Drug Containment Solution Industry Trends
- 5.3.2 Drug Containment Solution Market Drivers
- 5.3.3 Drug Containment Solution Market Challenges
- 5.3.4 Drug Containment Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Containment Solution Players by Revenue
- 6.1.1 Global Top Drug Containment Solution Players by Revenue (2021-2026)
- 6.1.2 Global Drug Containment Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Containment Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Containment Solution Head Office and Area Served
- 6.4 Global Drug Containment Solution Players, Product Type & Application
- 6.5 Global Drug Containment Solution Manufacturers Established Date
- 6.6 Global Drug Containment Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Containment Solution Market Size (2021-2032)
- 7.2 North America Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Containment Solution Market Size by Country (2021-2026)
- 7.4 North America Drug Containment Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Containment Solution Market Size (2021-2032)
- 8.2 Europe Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Containment Solution Market Size by Country (2021-2026)
- 8.4 Europe Drug Containment Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Containment Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Containment Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Containment Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Containment Solution Market Size (2021-2032)
- 10.2 South America Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Containment Solution Market Size by Country (2021-2026)
- 10.4 South America Drug Containment Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Containment Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Containment Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Containment Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Stevanato Group
- 12.1.1 Stevanato Group Company Information
- 12.1.2 Stevanato Group Business Overview
- 12.1.3 Stevanato Group Revenue in Drug Containment Solution Business (2021-2026)
- 12.1.4 Stevanato Group Drug Containment Solution Product Portfolio
- 12.1.5 Stevanato Group Recent Developments
- 12.2 BD
- 12.2.1 BD Company Information
- 12.2.2 BD Business Overview
- 12.2.3 BD Revenue in Drug Containment Solution Business (2021-2026)
- 12.2.4 BD Drug Containment Solution Product Portfolio
- 12.2.5 BD Recent Developments
- 12.3 AptarGroup
- 12.3.1 AptarGroup Company Information
- 12.3.2 AptarGroup Business Overview
- 12.3.3 AptarGroup Revenue in Drug Containment Solution Business (2021-2026)
- 12.3.4 AptarGroup Drug Containment Solution Product Portfolio
- 12.3.5 AptarGroup Recent Developments
- 12.4 Hergesheimer AG
- 12.4.1 Hergesheimer AG Company Information
- 12.4.2 Hergesheimer AG Business Overview
- 12.4.3 Hergesheimer AG Revenue in Drug Containment Solution Business (2021-2026)
- 12.4.4 Hergesheimer AG Drug Containment Solution Product Portfolio
- 12.4.5 Hergesheimer AG Recent Developments
- 12.5 Catalent, Inc.
- 12.5.1 Catalent, Inc. Company Information
- 12.5.2 Catalent, Inc. Business Overview
- 12.5.3 Catalent, Inc. Revenue in Drug Containment Solution Business (2021-2026)
- 12.5.4 Catalent, Inc. Drug Containment Solution Product Portfolio
- 12.5.5 Catalent, Inc. Recent Developments
- 12.6 West Pharmaceutical Services, Inc.
- 12.6.1 West Pharmaceutical Services, Inc. Company Information
- 12.6.2 West Pharmaceutical Services, Inc. Business Overview
- 12.6.3 West Pharmaceutical Services, Inc. Revenue in Drug Containment Solution Business (2021-2026)
- 12.6.4 West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio
- 12.6.5 West Pharmaceutical Services, Inc. Recent Developments
- 12.7 Schott AG
- 12.7.1 Schott AG Company Information
- 12.7.2 Schott AG Business Overview
- 12.7.3 Schott AG Revenue in Drug Containment Solution Business (2021-2026)
- 12.7.4 Schott AG Drug Containment Solution Product Portfolio
- 12.7.5 Schott AG Recent Developments
- 12.8 Stearate Group
- 12.8.1 Stearate Group Company Information
- 12.8.2 Stearate Group Business Overview
- 12.8.3 Stearate Group Revenue in Drug Containment Solution Business (2021-2026)
- 12.8.4 Stearate Group Drug Containment Solution Product Portfolio
- 12.8.5 Stearate Group Recent Developments
- 12.9 NIPRO
- 12.9.1 NIPRO Company Information
- 12.9.2 NIPRO Business Overview
- 12.9.3 NIPRO Revenue in Drug Containment Solution Business (2021-2026)
- 12.9.4 NIPRO Drug Containment Solution Product Portfolio
- 12.9.5 NIPRO Recent Developments
- 12.10 Owen Mumford Limited
- 12.10.1 Owen Mumford Limited Company Information
- 12.10.2 Owen Mumford Limited Business Overview
- 12.10.3 Owen Mumford Limited Revenue in Drug Containment Solution Business (2021-2026)
- 12.10.4 Owen Mumford Limited Drug Containment Solution Product Portfolio
- 12.10.5 Owen Mumford Limited Recent Developments
- 12.11 Psalmed AG
- 12.11.1 Psalmed AG Company Information
- 12.11.2 Psalmed AG Business Overview
- 12.11.3 Psalmed AG Revenue in Drug Containment Solution Business (2021-2026)
- 12.11.4 Psalmed AG Drug Containment Solution Product Portfolio
- 12.11.5 Psalmed AG Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst